Impairment of Quality of Life among Patients with Wearable Cardioverter Defibrillator Therapy (LifeVest®): A Preliminary Study

Figure 2

The additional items referring to WCD related QoL are depicted [percentage of patients]. (a) Without subgroups. (b) With subgroup differentiation comparing patients with 3 or less WCD warning signals (grey bar; n=44) to patients with at least 3 WCD warning signals (white bars; n=43). (c) With subgroup differentiation comparing patients with (striped bars; n=35) and without (white bars: n=43) ICD implantation after WCD therapy.

(a)

(b)

(c)